GO:0008138 protein tyrosine/serine/threonine phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008138 describes dual-specificity protein phosphatases that remove phosphate from serine, threonine, and tyrosine residues on proteins.
• These enzymes are central to MAPK signaling, acting as negative regulators or signal modulators in yeast and human cells.
• Dual-specificity phosphatases such as PYST2 are overexpressed in acute leukemia, linking GO:0008138 to cancer.
• PTPN11 (SHP2) mutations in leukemia create synthetic lethal dependencies that can be targeted by TNK2 inhibition.
• Protein phosphatases are conserved across evolution, with bacterial models like Bacillus subtilis revealing roles in life-stage transitions.
• CRISPR knockout, point-mutation, and overexpression models are essential to dissect the function of GO:0008138 enzymes in disease [1,7].
Description
Protein phosphorylation is a reversible post-translational modification that controls nearly every aspect of cell biology, and the enzymes that remove phosphate groups are equally important as the kinases that add them. GO:0008138, protein tyrosine/serine/threonine phosphatase activity, defines a class of enzymes known as dual-specificity phosphatases (DSPs) that can hydrolyze phosphate from all three hydroxyl-containing amino acids: serine, threonine, and tyrosine. This broad specificity distinguishes them from classical protein tyrosine phosphatases and serine/threonine phosphatases, which are restricted to one or two residue types. Dual-specificity phosphatases are critical for signal transduction, particularly in the mitogen-activated protein kinase (MAPK) pathways, where they dephosphorylate both the threonine and tyrosine residues in the activation loop of MAPKs, thereby shutting down or modulating the signal. In yeast, phosphatases such as Msg5 and Ptp2/Ptp3 have been extensively characterized as MAPK regulators, and this knowledge has been translated to human biology. In humans, DSPs like DUSP1, DUSP6, and PYST2 control cell proliferation, differentiation, and stress responses, and their dysregulation is implicated in cancer and other diseases. Understanding GO:0008138 is therefore essential for researchers studying signal transduction, cancer biology, and developmental processes. The ability to edit genes encoding these phosphatases using CRISPR technologies enables precise functional interrogation, from knockout to point mutations that mimic disease-associated variants [1,7]. This article synthesizes authoritative GO annotations and published literature to provide a comprehensive overview of the mechanism, genes, and research methods associated with protein tyrosine/serine/threonine phosphatase activity.
protein tyrosine/serine/threonine phosphatase activity At A Glance
| GO ID | GO:0008138 |
|---|---|
| GO term | protein tyrosine/serine/threonine phosphatase activity |
| Ontology | molecular_function |
| Synonym | dual-specificity protein phosphatase |
| Major function | Catalysis of phosphate removal from serine, threonine, and tyrosine residues on proteins |
| Catalytic mechanism | Cysteine-based nucleophilic attack forming a phosphoenzyme intermediate |
| Substrates | Phosphorylated serine, threonine, and tyrosine residues in proteins |
| Cofactors | No metal ions required; water is the nucleophile |
| Regulation | Regulated by subcellular localization, substrate specificity, and post-translational modifications |
What Is GO:0008138?
GO:0008138, protein tyrosine/serine/threonine phosphatase activity, is a molecular function defined by the catalysis of three related reactions: the hydrolysis of protein serine phosphate to protein serine and phosphate, protein threonine phosphate to protein threonine and phosphate, and protein tyrosine phosphate to protein tyrosine and phosphate. In simpler terms, it is the ability of an enzyme to remove phosphate groups from serine, threonine, or tyrosine residues on proteins, using water as a co-substrate. This dual-specificity activity is characteristic of a family of enzymes that share a conserved catalytic domain containing a cysteine residue essential for nucleophilic attack on the phosphate ester.
Why Is protein tyrosine/serine/threonine phosphatase activity Important in Cell Biology?
Protein tyrosine/serine/threonine phosphatases are indispensable for cellular signaling because they provide the off-switch for kinase cascades, ensuring that phosphorylation signals are transient and appropriately terminated. In the MAPK pathway, dual-specificity phosphatases dephosphorylate both the threonine and tyrosine residues in the activation loop of ERK, JNK, and p38, thereby controlling cell proliferation, differentiation, and apoptosis. Dysregulation of these phosphatases is linked to cancer, where overexpression of PYST2 contributes to acute leukemia, and mutations in PTPN11 (SHP2) drive leukemogenesis and create targetable vulnerabilities. Beyond cancer, these enzymes are involved in metabolic regulation, immune responses, and bacterial stress responses. Thus, studying GO:0008138 is critical for understanding both normal physiology and disease pathogenesis.
• Dual-specificity phosphatases are key negative regulators of MAPK signaling, controlling cell growth and differentiation.
• Overexpression of PYST2, a dual-specificity phosphatase, is observed in acute leukemia and may contribute to leukemogenesis.
• PTPN11 mutations in leukemia create synthetic lethal interactions with TNK2, offering a therapeutic strategy.
• Protein phosphatases are conserved in bacteria and regulate life-stage transitions, highlighting their broad biological importance.
• Dysregulation of phosphatase activity is implicated in inflammatory diseases and osteoarthritis, as suggested by competing endogenous RNA network analyses.
• Phosphatase activity influences glucose transport and metabolic pathways in hematopoietic cells.
• Dual-specificity phosphatases are potential drug targets, and polypharmacological approaches are being explored for cancer treatment.
• Understanding phosphatase specificity is essential for interpreting phosphoproteomics data and signaling networks.
• CRISPR-based editing of phosphatase genes enables functional studies in disease models [1,7].
• Phosphatase research benefits from comparative transcriptomics and proteomics to identify expression changes in disease.
Mechanism, Genes and Research Methods of protein tyrosine/serine/threonine phosphatase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the target protein and positions the phosphate group for removal.
Dual-specificity phosphatases recognize their substrates through a combination of active-site interactions and docking motifs. The catalytic domain contains a conserved CX5R motif, where the cysteine acts as a nucleophile and the arginine stabilizes the phosphate group. Substrate specificity is determined by the depth and shape of the active-site pocket, which in DSPs is relatively shallow, allowing accommodation of both phosphotyrosine and phosphothreonine/phosphoserine residues. In MAPK phosphatases, a kinase interaction motif (KIM) outside the catalytic domain mediates high-affinity binding to MAPKs, ensuring precise substrate targeting.
Catalytic Mechanism: Nucleophilic Attack and Phosphoenzyme Intermediate
In simple terms: The enzyme uses a cysteine residue to attack the phosphate, forming a temporary bond, then water breaks it to release phosphate.
The catalytic cycle begins with the deprotonation of the active-site cysteine by a nearby aspartate residue, generating a thiolate anion that attacks the phosphorus atom of the substrate phosphate. This nucleophilic attack displaces the serine, threonine, or tyrosine hydroxyl group and forms a covalent phosphocysteine intermediate. Subsequently, a water molecule, activated by the aspartate, hydrolyzes the intermediate, releasing inorganic phosphate and regenerating the free enzyme. This two-step mechanism is conserved across the dual-specificity phosphatase family and is essential for their activity.
Regulation by Localization and Post-Translational Modifications
In simple terms: The enzyme's activity is controlled by where it is in the cell and by chemical tags added to it.
Dual-specificity phosphatases are regulated by their subcellular localization, which determines access to substrates. For example, some MAPK phosphatases are nuclear, while others are cytoplasmic, and their shuttling is controlled by nuclear localization signals and export sequences. Post-translational modifications, such as phosphorylation and ubiquitination, can also modulate their activity, stability, and interactions. In leukemia, overexpression of PYST2 may overwhelm normal regulatory mechanisms, leading to aberrant MAPK signaling.
Role in MAPK Signaling Cascades
In simple terms: These enzymes turn off growth signals by removing phosphates from MAPK proteins.
The MAPK pathway is a central signaling cascade that transmits extracellular signals to the nucleus, and dual-specificity phosphatases act as critical off-switches. They dephosphorylate the TXY motif in the activation loop of ERK, JNK, and p38, thereby inactivating these kinases. In yeast, phosphatases such as Msg5, Ptp2, and Ptp3 have been shown to regulate pheromone response and stress-activated MAPK pathways. In human cells, DUSP1 (MKP-1) dephosphorylates ERK and p38, while DUSP6 (MKP-3) is specific for ERK. This regulation is essential for preventing uncontrolled proliferation.
Bacterial and Evolutionary Perspectives
In simple terms: Similar phosphatases exist in bacteria and help them respond to their environment.
Protein phosphorylation and dephosphorylation are ancient regulatory mechanisms present in bacteria. In Bacillus subtilis, phosphatases play roles in sporulation, competence, and stress responses. Comparative studies have identified dual-specificity phosphatases in diverse bacterial species, and their functions are being elucidated using genetic and biochemical approaches. These findings highlight the evolutionary conservation of GO:0008138 and provide model systems for understanding fundamental principles of phosphatase biology.
Key Genes Involved in GO:0008138 protein tyrosine/serine/threonine phosphatase activity
The following genes encode proteins with protein tyrosine/serine/threonine phosphatase activity (GO:0008138) or are closely associated with this function, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DUSP1 | Dephosphorylates ERK, JNK, and p38 MAPKs | Stress response, cancer, inflammation |
| DUSP6 | Specifically dephosphorylates ERK1/2 | Regulation of proliferation, cancer |
| DUSP9 | Dephosphorylates ERK and JNK | Metabolic regulation, cancer |
| PYST2 | Dual-specificity phosphatase overexpressed in leukemia | Leukemogenesis, potential therapeutic target |
| PTPN11 | Protein tyrosine phosphatase SHP2, also has dual-specificity activity | Leukemia, Noonan syndrome, synthetic lethality with TNK2 |
| MSG5 | Yeast MAPK phosphatase | Model for MAPK regulation |
| PTP2 | Yeast tyrosine phosphatase | Stress response, MAPK regulation |
| PTP3 | Yeast tyrosine phosphatase | MAPK regulation |
| CDC14 | Dual-specificity phosphatase involved in cell cycle | Cell cycle regulation, mitosis |
| PTEN | Dual-specificity phosphatase, tumor suppressor | Cancer, PI3K/AKT signaling |
| MTM1 | Myotubularin, lipid and protein phosphatase | Muscle function, disease |
| DUSP4 | Dephosphorylates ERK and JNK | Cancer, immune regulation |
| DUSP5 | Nuclear ERK-specific phosphatase | Feedback regulation of ERK |
| DUSP10 | Dephosphorylates JNK and p38 | Stress response, inflammation |
| DUSP16 | Dephosphorylates JNK and p38 | Innate immunity, cancer |
| LAFORIN | Dual-specificity phosphatase | Lafora disease, neurodegeneration |
| VHR | Vaccinia H1-related phosphatase, dual-specificity | Cell cycle, stress response |
How Is protein tyrosine/serine/threonine phosphatase activity Regulated?
The activity of protein tyrosine/serine/threonine phosphatases is regulated at multiple levels. Transcriptional control determines the abundance of these enzymes in response to growth factors, stress, and developmental cues. For example, DUSP1 is an immediate-early gene induced by growth factors and stress, providing negative feedback on MAPK signaling. Post-translational modifications, including phosphorylation, ubiquitination, and proteolysis, modulate their stability and catalytic activity. Subcellular localization further restricts substrate access; nuclear phosphatases regulate nuclear MAPK pools, while cytoplasmic phosphatases control cytoplasmic signaling. In leukemia, overexpression of PYST2 may result from aberrant transcriptional regulation, contributing to leukemogenesis. Additionally, synthetic lethal interactions, such as between PTPN11 mutations and TNK2 inhibition, reveal layers of pathway crosstalk that can be exploited therapeutically.
protein tyrosine/serine/threonine phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PYST2 | Acute leukemia | Knockout and overexpression in leukemia cell lines |
| PTPN11 | Juvenile myelomonocytic leukemia, Noonan syndrome | Point mutation knock-in in hematopoietic cells |
| PTEN | Cancer (multiple solid tumors) | Knockout in cancer cell lines and organoids |
| EPM2A | Lafora disease | Knockout in neurons and mouse models |
| DUSP1 | Inflammation, cancer | Knockout and overexpression in macrophages |
Dual-Specificity Phosphatases in Leukemia
Acute leukemia is characterized by uncontrolled proliferation of hematopoietic progenitors, and dual-specificity phosphatases are frequently dysregulated. PYST2, a dual-specificity MAPK phosphatase, is overexpressed in acute leukemia, suggesting that it contributes to leukemogenesis by modulating MAPK signaling. In addition, mutations in PTPN11, which encodes the SHP2 phosphatase, are common in juvenile myelomonocytic leukemia and other leukemias. These mutations create a synthetic lethal dependency on TNK2, and inhibition of TNK2 selectively kills PTPN11-mutant leukemia cells. These findings highlight the therapeutic potential of targeting phosphatases or their synthetic lethal partners.
Phosphatases in Solid Tumors and Signaling
Dual-specificity phosphatases play complex roles in solid tumors. PTEN, a dual-specificity phosphatase, is a well-known tumor suppressor that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate, antagonizing PI3K/AKT signaling. Loss of PTEN function leads to constitutive AKT activation and is observed in many cancers. Other DUSPs, such as DUSP1 and DUSP6, can act as tumor suppressors or oncogenes depending on context, by regulating the duration and amplitude of MAPK signaling. Polypharmacological approaches targeting histone deacetylases and other pathways are being explored to modulate phosphatase activity in cancer.
Neurodegeneration and Metabolic Disorders
Dual-specificity phosphatases are also implicated in neurodegeneration. Laforin, encoded by EPM2A, is a dual-specificity phosphatase that dephosphorylates glycogen, and mutations in EPM2A cause Lafora disease, a progressive myoclonus epilepsy. In metabolic disorders, phosphatases regulate insulin signaling and glucose transport; for example, interleukin-3 and oncogenes modulate glucose transport in murine bone marrow-derived cells, potentially through phosphatase-dependent mechanisms. Additionally, phosphatase activity is linked to osteoarthritis through competing endogenous RNA networks that include phosphatase genes.
From protein tyrosine/serine/threonine phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DUSP1 affect MAPK signaling and proliferation? | CRISPR knockout in HeLa or HEK293 cells |
| Does the PYST2 overexpression drive leukemia? | Overexpression in hematopoietic progenitor cells |
| Does a specific PTPN11 mutation create synthetic lethality with TNK2? | Point mutation knock-in in leukemia cell lines |
| How does PTEN phosphatase activity affect AKT signaling? | Knockout and knock-in of catalytically dead PTEN |
| What is the role of Laforin in glycogen metabolism? | Knockout in neuronal cells and mouse models |
| Does DUSP6 regulate ERK-dependent transcription? | Tagged knock-in for imaging and proteomics |
How to Study the protein tyrosine/serine/threonine phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify substrates of dual-specificity phosphatases |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Discover targets in PTPN11-mutant leukemia |
| RNA-seq | Transcriptional changes | Assess DUSP expression in cancer |
| Proteomics | Protein abundance and interactions | Compare phosphatase expression in disease models |
| Live-cell imaging | Dynamic localization and activity | Study MAPK regulation by DUSPs |
| In vitro phosphatase assays | Enzymatic activity | Measure catalytic efficiency of mutants |
| Co-immunoprecipitation | Protein-protein interactions | Identify phosphatase-substrate complexes |
Phosphoproteomics and Mass Spectrometry
Phosphoproteomics enables global identification of phosphorylation sites and quantification of changes upon modulation of phosphatase activity. By comparing wild-type and knockout cells, researchers can identify substrates and downstream signaling nodes. Mass spectrometry-based approaches can also detect the phosphoenzyme intermediate, providing mechanistic insights.
CRISPR Screens and Functional Genomics
Genome-wide CRISPR knockout screens can identify synthetic lethal interactions with phosphatase mutations, as demonstrated for PTPN11-mutant leukemia and TNK2 inhibition. These screens are powerful for discovering new therapeutic targets and understanding pathway crosstalk.
Transcriptomics and Proteomics in Disease Models
Comparative transcriptome and proteome analyses, such as those performed on donkey muscle, can reveal expression changes in phosphatase genes under different physiological conditions. In cancer, RNA-seq and proteomics can identify dysregulated phosphatases and their networks.
Imaging and Live-Cell Assays
Fluorescent biosensors and live-cell imaging can monitor phosphatase activity dynamics in real time. For example, FRET-based reporters for MAPK activity can be used to assess the impact of phosphatase knockout or overexpression. Localization studies using tagged phosphatases reveal spatiotemporal regulation.
How CRISPR Can Be Used to Study GO:0008138 protein tyrosine/serine/threonine phosphatase activity
Knockout
CRISPR knockout of genes encoding dual-specificity phosphatases, such as DUSP1 or PYST2, allows researchers to assess loss-of-function phenotypes. For example, knocking out PYST2 in leukemia cell lines can determine whether it is required for proliferation or survival. Knockout of PTPN11 in hematopoietic cells can model the effects of SHP2 loss and reveal synthetic lethal interactions.
Point Mutation
Point mutations in phosphatase genes, such as the catalytic cysteine-to-serine mutation, abolish enzymatic activity and are used to distinguish catalytic from scaffolding functions. Disease-associated mutations, like those in PTPN11, can be introduced to model leukemia and test targeted therapies. CRISPR prime editing or homology-directed repair can generate these precise mutations.
Knock-in
Knock-in of tagged phosphatases (e.g., GFP or HA) enables visualization and immunoprecipitation of endogenous proteins. Knock-in of disease-relevant mutations, such as those in EPM2A for Lafora disease, creates isogenic models for drug testing. Knock-in of reporter genes under the control of phosphatase promoters can monitor expression dynamics.
Overexpression
Overexpression of dual-specificity phosphatases, such as PYST2, can recapitulate the overexpression observed in leukemia and test its oncogenic potential. Overexpression of constitutively active or dominant-negative mutants can dissect signaling pathways. CRISPR activation (CRISPRa) can be used to overexpress endogenous genes without exogenous constructs.
How EDITGENE Supports protein tyrosine/serine/threonine phosphatase activity Research
Researchers studying protein tyrosine/serine/threonine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a disease or signaling pathway. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic editing, from knockout to point mutation, knock-in, and overexpression, as well as library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for protein tyrosine/serine/threonine phosphatase activity research.
Frequently Asked Questions About protein tyrosine/serine/threonine phosphatase activity
What is protein tyrosine/serine/threonine phosphatase activity?
It is a molecular function (GO:0008138) where an enzyme removes phosphate groups from serine, threonine, or tyrosine residues on proteins, using water. These enzymes are also called dual-specificity phosphatases.
What genes are involved in protein tyrosine/serine/threonine phosphatase activity?
Key genes include DUSP1, DUSP6, PYST2, PTPN11, PTEN, and EPM2A, among others. They encode enzymes that regulate MAPK signaling, cell growth, and metabolism [5,7].
How does dual-specificity phosphatase activity differ from tyrosine phosphatase activity?
Dual-specificity phosphatases can dephosphorylate serine, threonine, and tyrosine residues, whereas classical tyrosine phosphatases act only on tyrosine. This broader specificity allows them to regulate MAPK pathways by removing both phosphothreonine and phosphotyrosine in the activation loop.
What diseases are associated with protein tyrosine/serine/threonine phosphatases?
They are linked to acute leukemia (PYST2 overexpression, PTPN11 mutations), solid tumors (PTEN loss), Lafora disease (EPM2A mutations), and inflammatory conditions [1,5,7].
How can CRISPR be used to study protein tyrosine/serine/threonine phosphatases?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to dissect the function of these enzymes in disease and signaling. For example, knockout of PYST2 can test its role in leukemia.
What is the role of PTPN11 in leukemia?
Mutations in PTPN11 (SHP2) are common in juvenile myelomonocytic leukemia and create a synthetic lethal dependency on TNK2, which can be targeted therapeutically.
What are dual-specificity phosphatases?
They are enzymes with GO:0008138 activity that remove phosphate from serine, threonine, and tyrosine residues. They are key regulators of MAPK signaling and are involved in cancer and development.
How is protein tyrosine/serine/threonine phosphatase activity regulated?
It is regulated by transcription, post-translational modifications, subcellular localization, and interactions with substrates and scaffolds. For example, DUSP1 is induced by growth factors as negative feedback.
What methods are used to study protein tyrosine/serine/threonine phosphatases?
Common methods include phosphoproteomics, CRISPR screens, RNA-seq, proteomics, live-cell imaging, and in vitro phosphatase assays [1,5,6].
Can EDITGENE help create custom cell models for phosphatase research?
Yes, EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services tailored to study protein tyrosine/serine/threonine phosphatases [1,7].
Conclusion
Protein tyrosine/serine/threonine phosphatase activity (GO:0008138) is a fundamental molecular function that controls diverse cellular processes by reversing phosphorylation on serine, threonine, and tyrosine residues. Dual-specificity phosphatases are critical regulators of MAPK signaling, and their dysregulation contributes to leukemia, solid tumors, and neurological disorders [1,5,7]. Advances in CRISPR gene editing have made it possible to precisely model these enzymes in disease-relevant contexts, from knockout to point mutation and overexpression. By leveraging these tools, researchers can uncover new therapeutic targets and deepen our understanding of phosphatase biology.
References
- 1. Jenkins C et al.. 2018. Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.. Sci Signal 11(539) PMID: 30018082
- 2. Gangwal A et al.. 2023. Giving a signal: how protein phosphorylation helps Bacillus navigate through different life stages.. FEMS Microbiol Rev 47(4) PMID: 37533212
- 3. Yudaev P et al.. 2026. Current Research in Polypharmacology for Cancer Treatment Using Dual-Target Histone Deacetylase Inhibitors.. Int J Mol Sci 27(15) PMID: 42589262
- 4. Hua SL et al.. 2022. Constructing a competing endogenous RNA network for osteoarthritis.. Ann Transl Med 10(3):147 PMID: 35284549
- 5. Martín H et al.. 2005. Protein phosphatases in MAPK signalling: we keep learning from yeast.. Mol Microbiol 58(1):6-16 PMID: 16164545
- 6. Sun Y et al.. 2023. Comparative transcriptome and proteome analyses of the longissimus dorsi muscle for explaining the difference between donkey meat and other meats.. Anim Biotechnol 34(7):3085-3098 PMID: 36271875
- 7. Levy-Nissenbaum O et al.. 2003. Overexpression of the dual-specificity MAPK phosphatase PYST2 in acute leukemia.. Cancer Lett 199(2):185-92 PMID: 12969791
- 8. Ahmed N et al.. 1999. Distinct regulation of glucose transport by interleukin-3 and oncogenes in a murine bone marrow-derived cell line.. Biochem Pharmacol 57(4):387-96 PMID: 9933027
